Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 3,595.00
-15.00 (-0.42%)
At close: Oct 23, 2026
Protia Market Cap
Protia has a market cap or net worth of 69.45 billion as of October 23, 2026. It is the 29,749th most valuable company in the world and the 1,533rd biggest in South Korea. Its market cap has increased by 25.00% in one year.
Market Cap
69.45B
Enterprise Value
55.74B
Revenue
17.75B
Global Rank
Country Rank
#1,533 South Korea
PE Ratio
8.45
ChartMarket Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 69.45B, a decrease of -11.42%. That is a compound annual growth rate of -1.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 69.45B | -13.56% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 201.78B |
| 3billion | 168.02B |
| GC Medical Science | 97.05B |
| Inventera | 71.97B |
| HLB Panagene | 66.33B |
| GENINUS | 62.20B |
| Cytogen | 61.75B |
| Seoulin Bioscience | 34.86B |